作者: James Colandene , Shan Jiang , Valery Novokhatny , Thomas P. Zimmerman
DOI:
关键词:
摘要: The present invention provides a fibrinolytic composition useful as therapeutic for administration to patient having thrombotic occlusion. In one aspect of the invention, comprises reversibly inactivated acidified serine protease substantially free plasminogen activator, low buffering capacity buffer, and optionally, stabilizing agent. another plasmin